These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2636891

  • 1. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B, Antkiewicz-Michaluk L, Pilc A, Chojnacka-Wójcik E, Przegaliński E.
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [Abstract] [Full Text] [Related]

  • 2. The central action of carbamazepine as a potential antidepressant drug.
    Maj J, Chojnacka-Wójcik E, Lewandowska A, Tatarczyńska E, Wiczyńska B.
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Central effects following repeated treatment with antidepressant drugs.
    Maj J.
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [Abstract] [Full Text] [Related]

  • 6. Some central effects of tiflucarbine, a new potential antidepressant drug.
    Maj J, Rogóz Z, Sowińska H, Zalewski Z.
    Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antidepressant properties of some phosphodiesterase inhibitors.
    Przegaliński E, Bigajska K.
    Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
    [Abstract] [Full Text] [Related]

  • 12. Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro -beta-carbolin-1-one (B-193).
    Wiczyńska B, Chojnacka-Wójcik E, Rokosz-Pelc A, Mazela H, Przegaliński E.
    Pol J Pharmacol Pharm; 1989; 41(2):169-81. PubMed ID: 2556691
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Some central effects of opipramol given repeatedly.
    Skuza G, Rogóz Z, Sowińska H.
    Pol J Pharmacol Pharm; 1990; 42(5):425-31. PubMed ID: 2098752
    [Abstract] [Full Text] [Related]

  • 16. Psychopharmacological profile of dexamisole.
    Przegaliński E, Bigajska K, Siwanowicz J.
    Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
    [Abstract] [Full Text] [Related]

  • 17. 1-Pyridyl-3,4-dihydro-beta-carbolines: synthesis and central action.
    Misztal S, Boksa J, Chojnacka-Wójcik E, Tatarczyńska E, Wiczyńska B.
    Pol J Pharmacol Pharm; 1986; 38(5-6):555-65. PubMed ID: 3494988
    [Abstract] [Full Text] [Related]

  • 18. The action of compound WA-335 on the central nervous system.
    Maj J, Baran L, Sowińska H, Gancarczyk L.
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ, Porsolt R, Wettstein JG, Puech A, Soulard C, Pascaud X, Junien JL.
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.